289 related articles for article (PubMed ID: 31680952)
1. Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis.
Panin F; Peana AT
Front Pharmacol; 2019; 10():1164. PubMed ID: 31680952
[No Abstract] [Full Text] [Related]
2. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
3. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
[TBL] [Abstract][Full Text] [Related]
4. Baclofen for alcohol use disorder.
Minozzi S; Saulle R; Rösner S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
[TBL] [Abstract][Full Text] [Related]
5. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review.
Rosenstand NJ; Nielsen AS; Skøt L; Anhøj S; Nielsen DG; Højlund M; Mellentin AI
Curr Neuropharmacol; 2024; 22(6):1129-1143. PubMed ID: 36582063
[TBL] [Abstract][Full Text] [Related]
7. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
Jonas DE; Amick HR; Feltner C; Bobashev G; Thomas K; Wines R; Kim MM; Shanahan E; Gass CE; Rowe CJ; Garbutt JC
JAMA; 2014 May; 311(18):1889-900. PubMed ID: 24825644
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of alcohol dependence: a review of the clinical data.
Mann K
CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
Antonelli M; Sestito L; Tarli C; Addolorato G
Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
13. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
Morgane GL; Delphine LG; Guillaume K; Yves LJ
Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
[TBL] [Abstract][Full Text] [Related]
14. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Medications for treating alcohol use disorder: A narrative review.
Kranzler HR; Hartwell EE
Alcohol Clin Exp Res (Hoboken); 2023 Jul; 47(7):1224-1237. PubMed ID: 37526592
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis.
Bahji A; Bach P; Danilewitz M; Crockford D; Devoe DJ; El-Guebaly N; Saitz R
J Addict Med; 2022 Nov-Dec 01; 16(6):630-638. PubMed ID: 35653782
[TBL] [Abstract][Full Text] [Related]
19. Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies.
Florence L; Lassi DLS; Kortas GT; Lima DR; de Azevedo-Marques Périco C; Andrade AG; Torales J; Ventriglio A; De Berardis D; De Aquino JP; Castaldelli-Maia JM
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326342
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for adolescent alcohol use disorder.
Clark DB
CNS Drugs; 2012 Jul; 26(7):559-69. PubMed ID: 22676261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
